Page 17 - Mecklenburg_Medicine_March-2018
P. 17
Chemotherapy may destroy your cancer
but it doesn’t have to destroy your hair
We are the only oncology group in the Charlotte region to offer DigniCap®
New Clinical Trials
Head & Neck
Randomized, double-blind, Phase 3 Study of
Avelumab in Combination with Standard of Care
Chemoradiotherapy (Cisplatin Plus Definitive
Radiation Therapy) Versus Standard of Care
Chemoradiotherapy in the Front-line Treatment of
Patients with Locally Advanced Squamous Cell
Carcinoma of the Head and Neck
Metastatic Breast
Double-blind, placebo-controlled, Phase 2
trial of Seribantumab Plus Fulvestrant in
Postmenopausal Women with Hormone
Receptor-positive, Heregulin Positive (HRG+),
HER2 Negative Metastatic Breast Cancer Whose
Disease Progressed After Prior Systemic Therapy
Justin Favaro MD PhD • Jason Shultz MD • Catherine Moore MD • Dipika Misra MD For patient enrollment:
email lauren.jordan@djlresearch.com
or call 704-247-9179, ext. 202
704-342-1900 n Randolph Road & Pineville-Matthews Road n OncologyCharlotte.com
Mecklenburg Medicine • March 2018 | 17
